Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting

In our clinical setting, generic LEV was determined to be bioequivalent to brand LEV. Furthermore, seizures frequency or/and adverse events were not affected upon switching from brand to generic LEV.